These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27259980)

  • 1. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
    Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
    Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
    Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
    J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
    Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
    Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.
    Papadas A; Deb G; Cicala A; Officer A; Hope C; Pagenkopf A; Flietner E; Morrow ZT; Emmerich P; Wiesner J; Arauz G; Bansal V; Esbona K; Capitini CM; Matkowskyj KA; Deming DA; Politi K; Abrams SI; Harismendy O; Asimakopoulos F
    Cell Rep; 2022 Aug; 40(7):111201. PubMed ID: 35977482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Versican in the Tumor Microenvironment.
    Papadas A; Asimakopoulos F
    Adv Exp Med Biol; 2020; 1272():55-72. PubMed ID: 32845502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.
    Nandadasa S; Foulcer S; Apte SS
    Matrix Biol; 2014 Apr; 35():34-41. PubMed ID: 24444773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new mouse mutant with cleavage-resistant versican and isoform-specific versican mutants demonstrate that proteolysis at the Glu
    Nandadasa S; Burin des Roziers C; Koch C; Tran-Lundmark K; Dours-Zimmermann MT; Zimmermann DR; Valleix S; Apte SS
    Matrix Biol Plus; 2021 Jun; 10():100064. PubMed ID: 34195596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
    Gupta N; Kumar R; Sharma A
    Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis.
    Asano K; Nelson CM; Nandadasa S; Aramaki-Hattori N; Lindner DJ; Alban T; Inagaki J; Ohtsuki T; Oohashi T; Apte SS; Hirohata S
    Sci Rep; 2017 Dec; 7(1):17225. PubMed ID: 29222454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
    Dhakal B; Pagenkopf A; Mushtaq MU; Cunningham AM; Flietner E; Morrow Z; Papadas A; Hope C; Leith C; Hematti P; Hari P; Callander NS; Asimakopoulos F
    Leuk Lymphoma; 2019 Oct; 60(10):2558-2562. PubMed ID: 30845856
    [No Abstract]   [Full Text] [Related]  

  • 12. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
    Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
    Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
    Gupta N; Khan R; Kumar R; Kumar L; Sharma A
    Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-dependent bioactivity of versican fragments.
    Timms KP; Maurice SB
    Glycobiology; 2020 May; 30(6):365-373. PubMed ID: 31651027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS4 is a crucial proteolytic enzyme for versican cleavage in the amnion at parturition.
    Li MD; Lu JW; Zhang F; Lei WJ; Pan F; Lin YK; Ling LJ; Myatt L; Wang WS; Sun K
    Commun Biol; 2024 Mar; 7(1):301. PubMed ID: 38461223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate.
    Hirani P; McDermott J; Rajeeve V; Cutillas PR; Jones JL; Pennington DJ; Wight TN; Santamaria S; Alonge KM; Pearce OMT
    Cancer Res Commun; 2024 Apr; 4(4):970-985. PubMed ID: 38517140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Versikine Levels by Enzyme-Linked Immunosorbent Assay (ELISA).
    Minns AF; Santamaria S
    Methods Mol Biol; 2024; 2747():83-93. PubMed ID: 38038934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.
    McRae N; Forgan L; McNeill B; Addinsall A; McCulloch D; Van der Poel C; Stupka N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of ADAMTS5 does not affect aggrecan or versican degradation but promotes glucose uptake and proteoglycan synthesis in murine adipose derived stromal cells.
    Gorski DJ; Xiao W; Li J; Luo W; Lauer M; Kisiday J; Plaas A; Sandy J
    Matrix Biol; 2015 Sep; 47():66-84. PubMed ID: 25840345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.